Biopharma Business

Tag "Multikine"

CEL-SCI receives new European patent for investigational immunotherapy

    CEL-SCI receives new European patent for investigational immunotherapy

The European Patent Office has issued a new patent to biotechnology company, CEL-SCI, for its lead investigational immunotherapy, which is undergoing a Phase III clinical trial for head and neck

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements